Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Abstract Human papillomavirus (HPV)-induced cervical cancer is a major health issue among women from the poorly/under-developed sectors of the world. It accounts for a high-mortality rate because of its late diagnosis and poor prognosis. Initial establishment and subsequent progression of this form of cancer are completely dependent on two major oncogenes E6 and E7, which are expressed constituti
Abstract Human papillomavirus (HPV)-induced cervical cancer is a major health issue among women from the poorly/under-developed sectors of the world. It accounts for a high-mortality rate because of its late diagnosis and poor prognosis. Initial establishment and subsequent progression of this form of cancer are completely dependent on two major oncogenes E6 and E7, which are expressed constitutively leading to tumorigenesis. Thus, manipulation of these genes represents the most successful form of cervical cancer therapy. In the present article, information on structural, functional, and…
related reading
- Frontiers | Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapyfrontiersin.org
- Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer - PMCncbi.nlm.nih.gov
- Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer - PubMedpubmed.ncbi.nlm.nih.gov
- RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis | Journal of Biomedical Science | Springer Nature Linkjbiomedsci.biomedcentral.com
- HPV and Cancer - NCIcancer.gov
- Human papillomavirus vaccination - UpToDateuptodate.com
- Targeting telomerase for cancer therapy | Oncogenenature.com
- 人類乳突瘤病毒(Human papilloma virus; HPV) 與子宮頸癌的關係::台灣癌症基金會canceraway.org.tw
- Epigenetic regulation during cancer transitions across 11 tumour typesnature.com
- HPV vaccine cutting cervical cancer by nearly 90%bbc.com
- Nasopharyngeal Carcinoma(Archived) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance - PMCncbi.nlm.nih.gov